OREANDA-NEWS. Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has in an official letter informed KASE of June 23, 2016 decisions of its Board of Directors.

Said information is available on KASE website (in Russian) – http://www.kase.kz/files/emitters/CHFM/chfm_info_reshenie_sd_230616.pdf